Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 7,326–7,350 of 7,816 matching trials · page 294 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease NCT00090116 Neramexane Runs in: United States · 34 sites |
PHASE3 other |
COMPLETED | 400 | Forest Laboratories INDUSTRY |
2012-03-05 |
|
An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease NCT00097916 memantine HCl Runs in: United States · 9 sites |
PHASE3 symptomatic-cholinergic |
COMPLETED | 34 | Forest Laboratories INDUSTRY |
2012-03-05 |
|
Escitalopram Treatment of Patients With Agitated Dementia NCT00260624 Escitalopram (Lexapro) Runs in: United States · 3 sites |
PHASE4 other |
COMPLETED | 20 | University of Rochester OTHER |
2012-02-24 |
|
Prevention of Stroke and Dementia in Primary Care NCT01107548 Systematic detection of vascular risk factors and subsequent eviden... Runs in: Germany · 1 site |
NA other |
TERMINATED | 3,908 | Technical University of Munich OTHER |
2012-02-20 |
|
Riluzole in Huntington's Disease NCT00277602 Riluzole |
PHASE3 other |
COMPLETED | 537 | Sanofi INDUSTRY |
2012-02-17 |
|
Dementia Registry for Parkinson's Disease NCT01251094 Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 30 | China Medical University Hospital OTHER |
2012-02-14 |
|
Evaluation of [18F] FEPPA and PET Imaging as a Marker of Inflammation in Subjects With Neurological Conditions NCT00970333 [18F]-FEPPA Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 3 | Institute for Neurodegenerative Disorders OTHER |
2012-02-08 |
|
Effect of Tai Chi on Osteoarthritic Knee Pain in Elders With Mild Dementia NCT01528566 Tai Chi; Attention control Runs in: United States · 1 site |
NA other |
COMPLETED | 55 | University of Arkansas OTHER |
2012-02-08 |
|
Escalating Dose Study in Healthy Volunteers With SEN0014196 NCT01521832 SEN0014196; SEN0014196; SEN0014196; SEN0014196; SEN0014196; SEN0014... Runs in: United Kingdom · 1 site |
PHASE1 other |
COMPLETED | 88 | Siena Biotech S.p.A. INDUSTRY |
2012-02-07 |
|
MemoryXL Effects on Mild Cognitive Impairment Patients NCT00903695 Memory XL; placebo Runs in: United States · 2 sites |
PHASE2 other |
TERMINATED | 10 | University of Oklahoma OTHER |
2012-01-26 |
|
Effects of Serotonin Inhibitors on Patient-controlled Analgesia Related Nausea and Vomiting NCT01517438 agitation |
NA other |
COMPLETED | 21 | Seoul National University Hospital OTHER |
2012-01-25 |
|
Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease NCT00183378 Walking Program; Light Exposure Program; Combined Education, Walkin... Runs in: United States · 1 site |
NA other |
COMPLETED | 132 | University of Washington OTHER |
2012-01-13 |
|
Follow-up Study of the Alzheimer's Disease Anti-Inflammatory Prevention Trial NCT01417130 Runs in: United States · 6 sites |
NA anti-inflammatory |
UNKNOWN | 1,650 | Seattle Institute for Biomedical and Clinical Research OTHER |
2012-01-09 |
|
Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's Disease NCT01019421 Lu AE58054; Placebo Runs in: Australia; Canada; Czechia; Germany; Italy; Poland; Spain · 51 sites |
PHASE2 symptomatic-cholinergic |
COMPLETED | 278 | H. Lundbeck A/S INDUSTRY |
2012-01-06 |
|
Mirtazapine in Alzheimer-associated Weight Loss NCT01505504 mirtazapine Runs in: Belgium · 1 site |
NA other |
COMPLETED | 22 | Brugmann University Hospital OTHER |
2012-01-06 |
|
Safety and Tolerability of AFFITOPE AD03 NCT01309763 AFFITOPE AD03; AFFITOPE AD03 + Alum Runs in: Austria · 1 site |
PHASE1 other |
COMPLETED | 28 | Affiris AG INDUSTRY |
2011-12-20 |
|
Use of MEOPA (Equimolar Mixture of Nitrogen Protoxide and Oxygen) for Elderly With Dementia NCT00822224 MEOPA Runs in: France · 1 site |
NA other |
COMPLETED | 50 | Centre Hospitalier Universitaire de Nice OTHER |
2011-12-09 |
|
Evaluation of Apathy Using Attentional Reaction Test in Neurodegenerative Diseases NCT00833274 computerized test Runs in: France · 1 site |
NA other |
COMPLETED | 70 | Centre Hospitalier Universitaire de Nice OTHER |
2011-12-09 |
|
Four Interventions in the Management of Psychomotor Agitation, Safety and Efficacy Evaluation NCT01485692 haloperidol+promethazine; haloperidol + midazolam; olanzapine; Ziprasidone Runs in: Brazil · 1 site |
NA other |
COMPLETED | 120 | University of Sao Paulo OTHER |
2011-12-05 |
|
Infant Psychiatry Home Visitation Program NCT01483521 Clinical home visitation Runs in: Canada · 1 site |
NA other |
COMPLETED | 40 | University of British Columbia OTHER |
2011-12-01 |
|
Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD) NCT00623103 Rivastigmine capsule; Rivastigmine transdermal patch Runs in: Argentina; Australia; Austria; Belgium; Canada; France; G... · 127 sites |
PHASE3 symptomatic-cholinergic |
COMPLETED | 583 | Novartis INDUSTRY |
2011-11-28 |
|
Effectiveness of an Adaptive Treatment Model for At-risk Family Caregivers NCT00632684 Interviews with a single treatment planning session; Adaptive treat... Runs in: United States · 1 site |
NA other |
COMPLETED | 65 | Penn State University OTHER |
2011-11-23 |
|
Evaluation of the Efficacy of Varenicline on Cognition, Safety, Tolerability and Pharmacokinetics in Subjects With Mild-to-Moderate Alzheimer's Disease NCT00744978 Varenicline; Placebo Runs in: South Korea · 8 sites |
PHASE2 other |
COMPLETED | 66 | Pfizer INDUSTRY |
2011-11-22 |
|
EEG Objectification in Neuropsychiatry NCT01476228 EEG recording Runs in: Israel · 1 site |
NA other |
UNKNOWN | 100 | Hadassah Medical Organization OTHER |
2011-11-22 |
|
Cognitive Correlates of Antidepressant Treatment Response in Elders NCT01477268 Zoloft (antidepressant) Runs in: Canada · 1 site |
PHASE4 other |
COMPLETED | 30 | Unity Health Toronto OTHER |
2011-11-22 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial